Drugs / Chitin microparticles
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00443495 | Oct 2006 → Mar 2007 | seasonal allergic rhinitis | CMP Therapeutics Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chitin microparticles | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00443495 ↗ |
| Known as | CMP | “Chitin microparticles (CMP) has been demonstrated in animal studies that have modelled allergic rhinitis to be effective against a wide range of common respiratory allergens.” NCT00443495 ↗ |
| Route | Intranasal | “Chitin microparticles by nasal route” NCT00443495 ↗ |